Ovid Therapeutics (OVID) Current Assets (2016 - 2026)
Ovid Therapeutics (OVID) posted Current Assets of $160.1 million for Q1 2026, up 115.34% on a QoQ basis from $74.4 million in Q4 2025, and up 248.74% year-over-year from $45.9 million in Q1 2025.
Ovid Therapeutics (OVID) Current Assets (2016 - 2026) Analysis & Trends
Ovid Therapeutics' Current Assets history runs 11 years deep, the most recent figure standing at $160.1 million for Q1 2026.
- Quarterly Current Assets rose 248.74% year-over-year to $160.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $160.1 million (up 248.74% YoY) and the FY2025 annual result came in at $74.4 million, up 32.94% from the prior year.
- Current Assets was $160.1 million for Q1 2026 at Ovid Therapeutics, up from $74.4 million in the prior quarter.
- Across five years, Current Assets topped out at $170.1 million in Q1 2022 and bottomed at $28.8 million in Q3 2025.
- A 5-year average of $98.1 million and a median of $93.2 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2025 — Current Assets tumbled 56.21% — and 2026, when it jumped 248.74%.
- Ovid Therapeutics' Current Assets stood at $131.4 million in 2022, then slipped by 16.58% to $109.6 million in 2023, then tumbled by 48.96% to $55.9 million in 2024, then surged by 32.94% to $74.4 million in 2025, then jumped by 115.34% to $160.1 million in 2026.
- Business Quant data shows OVID's Current Assets at $160.1 million in Q1 2026, $74.4 million in Q4 2025, and $28.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 73.04 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 3.59 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 6.60 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 1.97 Bn |
| 10 | Ovid Therapeutics | 118.66 Mn | -36.86 Mn | - | 160.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 160.15 Mn |
| Dec 31, 2025 | 74.37 Mn |
| Sep 30, 2025 | 28.82 Mn |
| Jun 30, 2025 | 42.09 Mn |
| Mar 31, 2025 | 45.92 Mn |
| Dec 31, 2024 | 55.94 Mn |
| Sep 30, 2024 | 65.83 Mn |
| Jun 30, 2024 | 80.89 Mn |
| Mar 31, 2024 | 93.17 Mn |
| Dec 31, 2023 | 109.60 Mn |
| Sep 30, 2023 | 91.71 Mn |
| Jun 30, 2023 | 102.17 Mn |
| Mar 31, 2023 | 119.52 Mn |
| Dec 31, 2022 | 131.38 Mn |
| Sep 30, 2022 | 140.50 Mn |
| Jun 30, 2022 | 156.08 Mn |
| Mar 31, 2022 | 170.09 Mn |
| Dec 31, 2021 | 190.48 Mn |
| Sep 30, 2021 | 205.06 Mn |
| Jun 30, 2021 | 215.87 Mn |